Inogen Announces CEO Transition | Company & Finance

GOLETA, Calif.–(Small business WIRE)–Jan 27, 2021–

Inogen, Inc. (NASDAQ: INGN), a professional medical technological know-how organization giving impressive respiratory items for use in the homecare placing, introduced right now that its Board of Administrators has appointed Nabil Shabshab as Inogen’s President and Chief Govt Officer (“CEO”), efficient February 8, 2021. In addition, Mr. Shabshab was appointed to the Board of Administrators, helpful February 8, 2021. Mr. Shabshab will realize success Scott Wilkinson, who is retiring as President, CEO, and as a director, in just about every circumstance efficient February 8, 2021.

Heath Lukatch, Ph.D., Inogen’s Chairman, explained, “On behalf of the Board of Directors, I would like to congratulate Nabil on this appointment and thank Scott for his important contributions to Inogen in excess of the very last fifteen decades. For the duration of Scott’s tenure with the company, Inogen turned the market place chief in portable oxygen concentrators, with ideal-in-class merchandise and an progressive go to industry solution. Nabil is a highly proficient and professional government who we believe that will be significant to Inogen’s ideas for growth, as we go on to operate in the direction of bettering the life of respiratory remedy individuals.”

“I am honored for the prospect to guide Inogen in our mission to raise the freedom and independence for respiratory patients and to make our technologies the conventional of treatment,” claimed Mr. Shabshab. “I appear forward to driving the upcoming stage of Inogen’s accomplishment as we continue to seek means to increase individual obtain to our technologies, extend the effects we have on people, generate growth enterprise, and enhance benefit for our stockholders.”

“I am grateful to have led this superb enterprise and to be a section of improving upon nearly a million patients’ life with our modern transportable oxygen concentrators,” reported Mr. Wilkinson. “As I previously disclosed, this is the correct time for me individually to retire as CEO, and I think that Inogen will keep on to enhance affected person and physician awareness of our products though also focusing on delivering great support.”

Most a short while ago, Mr. Shabshab, 56, has served as All over the world President of Diabetic issues Care and Digital Wellbeing at Becton Dickinson and Corporation, a leading clinical know-how business, since August 2017. Prior to that, because August 2011, Mr. Shabshab served as Becton Dickinson’s Main Marketing and advertising Officer and Govt Vice President of Strategic Preparing. Prior to Becton Dickinson, Mr. Shabshab served as EVP, Global Portfolio, Chief Promoting Officer and Head of RD&E of Diversey, Inc., a cleansing and sanitation remedies organization from 2006 to 2010. In his prior roles Mr. Shabshab served as Principal with The Zyman Group, as Vice President, Customer Remedies and Consulting with Symphony IRI, and in a variety of revenue and advertising and marketing roles in pharmaceutical and purchaser items organizations together with Warner Lambert / Pfizer, the Coca-Cola Corporation, and Fronterra. Mr. Shabshab holds an MBA from Northwestern University Kellogg University of Administration and a B.S. in Laptop or computer Sciences from American Lebanese University.

We are a clinical technological know-how business offering innovative respiratory goods for use in the homecare location. We primarily build, manufacture and market place progressive transportable oxygen concentrators made use of to provide supplemental long-time period oxygen therapy to people struggling from continual respiratory disorders.

Cautionary Observe About Forward-On the lookout Statements

This push launch incorporates ahead-searching statements in the that means of the Non-public Securities Litigation Reform Act of 1995, together with, amongst other folks, statements with regard to the introduced management and organizational alterations, statements regarding or implying Inogen’s future fiscal functionality, tendencies and chances affecting Inogen, and the ability of management staff and our board of administrators to contribute to rising affected person obtain to our products and solutions and systems, increasing our enterprise, and rising worth for our stockholders. Forward-searching statements are subject matter to a lot of risks and uncertainties that could lead to genuine success to differ materially from now expected final results, including, but not limited to, threats linked to its introduced management and organizational alterations, threats arising from the likelihood that Inogen will not comprehend anticipated income the pitfalls similar to the COVID-19 public wellbeing unexpected emergency the impact of improvements in reimbursement prices and reimbursement and regulatory procedures the probable reduction of critical workforce, clients, or suppliers threats relating to Inogen’s acquisition of New Aera and the integration of New Aera’s small business and functions inside these of Inogen challenges relating to reimbursement coding of the Tidal Support © Ventilator (TAV) the possibility that Inogen will not comprehend expected income from the technological innovation acquired from New Aera or that expenditures and charges will exceed Inogen’s anticipations mental home hazards if Inogen is unable to safe and manage patent or other intellectual assets security for the intellectual residence utilised in its products and intellectual residence dangers relating to the acquisition of New Aera, which includes the possibility of mental home litigation. In addition, Inogen’s company is matter to quite a few further pitfalls and uncertainties, including, among some others, dangers relating to market place acceptance of its products level of competition its profits, internet marketing and distribution abilities its planned profits, internet marketing, and investigate and advancement activities interruptions or delays in the source of components or materials for, or production of, its products seasonal versions unanticipated improves in fees or charges and challenges related with worldwide functions. Info on these and supplemental challenges, uncertainties, and other information and facts affecting Inogen’s company and working results are contained in Inogen’s Quarterly Report on Variety 10-Q for the quarter finished September 30, 2020 and its subsequent SEC filings. These ahead-hunting statements talk only as of the day hereof. Inogen disclaims any obligation to update these ahead-searching statements other than as may perhaps be needed by law.

Get in touch with: Investor Relations Call:


Sector Search phrase: Healthcare Devices Wellbeing

Copyright Organization Wire 2021.

PUB: 01/27/2021 06:25 AM/DISC: 01/27/2021 06:25 AM

Copyright Business Wire 2021.